Association between RAD 51 rs1801320 and susceptibility to glioblastoma

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Glioblastoma is an aggressive brain tumor with a poor prognosis.
• DNA repair gene polymorphisms may influence treatment sensitivity.
• The role of these polymorphisms in glioblastoma susceptibility is unclear.

Purpose of the Study:

• To investigate the association between specific DNA repair gene polymorphisms (XRCC1 rs25487, XRCC3 rs861539, RAD51 rs1801320) and glioblastoma susceptibility.
• To determine if these genetic variations act as predisposing factors for glioblastoma development.

Main Methods:

• Case-control study involving 85 glioblastoma patients and 70 controls.
• Utilized data from the 1000 Genomes Project (98 Tuscans) for additional analysis.
• Genotyping of XRCC1 rs25487, XRCC3 rs861539, and RAD51 rs1801320 polymorphisms.

Main Results:

• Carriage of the RAD51 rs1801320 GC genotype was associated with a significantly increased risk of glioblastoma (OR 3.0087, p=0.0010).
• The RAD51 rs1801320 C allele also showed a significant association with glioblastoma risk (OR 2.5674, p=0.0032).
• Combined analysis revealed that the RAD51 rs1801320 C allele, particularly with XRCC1 rs25487 G and XRCC3 rs861539 C alleles, further elevated glioblastoma risk (p=0.0053).

Conclusions:

• RAD51 rs1801320 polymorphisms are associated with an increased susceptibility to glioblastoma.
• These findings suggest a potential role for DNA repair gene variations in glioblastoma predisposition.
• Further research is warranted to explore the clinical implications of these genetic markers.